These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29025567)

  • 1. Cardioprotective Properties of ANGPTL3 Deficiency.
    Guo Y; Luo F; Xu D
    J Am Coll Cardiol; 2017 Oct; 70(16):2098-2099. PubMed ID: 29025567
    [No Abstract]   [Full Text] [Related]  

  • 2. ANGPTL3: A Gene, a Protein, a New Target? Aye, There's the Rub!
    Genest J
    J Am Coll Cardiol; 2017 Apr; 69(16):2064-2066. PubMed ID: 28385497
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiopoietin-like protein 3 modulates barrier properties of human glomerular endothelial cells through a possible signaling pathway involving phosphatidylinositol-3 kinase/protein kinase B and integrin alphaVbeta3.
    Li Y; Sun L; Xu H; Fang Z; Yao W; Guo W; Rao J; Zha X
    Acta Biochim Biophys Sin (Shanghai); 2008 Jun; 40(6):459-65. PubMed ID: 18535744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a mammalian angiopoietin-related protein expressed specifically in liver.
    Conklin D; Gilbertson D; Taft DW; Maurer MF; Whitmore TE; Smith DL; Walker KM; Chen LH; Wattler S; Nehls M; Lewis KB
    Genomics; 1999 Dec; 62(3):477-82. PubMed ID: 10644446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
    Fazio S; Minnier J; Shapiro MD; Tsimikas S; Tarugi P; Averna MR; Arca M; Tavori H
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3340-3348. PubMed ID: 28633452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotides targeting ANGPTL3.
    Luo F; Guo Y; Li X; Hu X; Fang Z
    Int J Cardiol; 2018 Apr; 256():8. PubMed ID: 29454421
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetics: ANGPTL3 deficiency protects from CAD.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2017 Jun; 14(6):316. PubMed ID: 28470173
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply: Loss-of-Function Mutations to Estimate Pharmacological ANGPTL3 Inhibition.
    Stitziel NO; Musunuru K; Kathiresan S
    J Am Coll Cardiol; 2017 Oct; 70(16):2099-2100. PubMed ID: 29025568
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angptl3(angiopoietin-like 3)].
    Shimizugawa T; Ando Y; Ono M
    Nihon Rinsho; 2004 Jun; 62(6):1170-4. PubMed ID: 15206159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concerns on the Genetic or Therapeutic Antagonism of ANGPTL3.
    Luo F; Guo Y; Fang Z; Li X
    J Am Coll Cardiol; 2017 Oct; 70(16):2099. PubMed ID: 29025569
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiopoietin-like 3 regulates hepatocyte proliferation and lipid metabolism in zebrafish.
    Lee SH; So JH; Kim HT; Choi JH; Lee MS; Choi SY; Kim CH; Kim MJ
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1237-42. PubMed ID: 24685482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ANGPTL3 in controlling lipoprotein metabolism.
    Tikka A; Jauhiainen M
    Endocrine; 2016 May; 52(2):187-93. PubMed ID: 26754661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke.
    Li WJ; Yin RX; Cao XL; Chen WX; Huang F; Wu JZ
    Lipids Health Dis; 2018 Feb; 17(1):30. PubMed ID: 29454388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and regulation of angiopoietin-like proteins 3 and 4.
    Li C
    Curr Opin Lipidol; 2006 Apr; 17(2):152-6. PubMed ID: 16531751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
    El-Shal AS; Zidan HE; Rashad NM; Wadea FM
    Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of angiopoietin-like proteins 3 and 4 to hemodialysis.
    Mahmood D; Makoveichuk E; Nilsson S; Olivecrona G; Stegmayr B
    Int J Artif Organs; 2014 Jan; 37(1):13-20. PubMed ID: 24634330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-like 3 in lipoprotein metabolism.
    Kersten S
    Nat Rev Endocrinol; 2017 Dec; 13(12):731-739. PubMed ID: 28984319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
    Miida T; Hirayama S
    Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of angiopoietin-like 3 associated with puromycin-induced podocyte damage.
    Jia R; Hong X; Li S; Haichun Y; Chuanming H
    Nephron Exp Nephrol; 2010; 115(3):e38-45. PubMed ID: 20424482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects.
    Hatsuda S; Shoji T; Shinohara K; Kimoto E; Mori K; Fukumoto S; Koyama H; Emoto M; Nishizawa Y
    J Vasc Res; 2007; 44(1):61-6. PubMed ID: 17191020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.